| Name | Title | Contact Details |
|---|
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.
To enhance the diagnosis and treatment of cardiovascular disease through the development of innovative optical diagnostic and therapeutic devices.
Founded in 1934, Beekley Corporation has evolved into the world leading supplier of simple innovative medical products that help imaging, surgical, and radiation therapy professionals save time, improve accuracy, enhance communication and provide a better patient experience. Beekley introduced the X-SPOT, the first ever professional skin marker for diagnostic imaging in 1984. The X-SPOT® replaced a variety of makeshift methods used at the time for communicating an area of concern on film. It quickly became a staple in radiology departments across the country and its quick adaptation in all radiology modalities led Beekley to devote itself to the research and development of simple, low cost, disposable products that would help imaging professionals improve communication, productivity, and patient care. Today, Beekley`s product line has grown to include a broad range of radiologic skin markers, biopsy and patient care devices for Mammography; Breast Biopsy; Radiation Therapy; MRI; CT-Scan and General Radiology.
OMNIlife science, Inc. (Main) is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
ENOCHS is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.